Mobia Medical (NASDAQ:MOBI) Rating Increased to Hold at Wall Street Zen

Mobia Medical (NASDAQ:MOBI) was upgraded by research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued to investors on Sunday.

Several other research firms also recently weighed in on MOBI. Wolfe Research assumed coverage on shares of Mobia Medical in a report on Tuesday, June 2nd. They set an “outperform” rating on the stock. BTIG Research assumed coverage on shares of Mobia Medical in a report on Tuesday, June 2nd. They set a “buy” rating and a $19.00 price objective on the stock. Zacks Research upgraded shares of Mobia Medical to a “hold” rating in a report on Wednesday, June 3rd. The Goldman Sachs Group assumed coverage on shares of Mobia Medical in a report on Tuesday, June 2nd. They set a “buy” rating and a $31.00 price objective on the stock. Finally, JPMorgan Chase & Co. began coverage on shares of Mobia Medical in a report on Tuesday, June 2nd. They set an “overweight” rating and a $15.00 price objective on the stock. Five research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $20.25.

Mobia Medical Stock Performance

Shares of NASDAQ MOBI opened at $12.31 on Friday. Mobia Medical has a 12-month low of $10.19 and a 12-month high of $14.77. The firm has a market cap of $409.30 million, a P/E ratio of 66.00 and a beta of 2.84.

Mobia Medical (NASDAQ:MOBI) last released its quarterly earnings data on Thursday, June 4th. The company reported $999.00 earnings per share for the quarter. The business had revenue of $12.07 million for the quarter.

Insider Activity

In other Mobia Medical news, Director William T. Harrington bought 533,333 shares of the business’s stock in a transaction on Monday, May 11th. The stock was purchased at an average price of $15.00 per share, for a total transaction of $7,999,995.00. Following the completion of the transaction, the director directly owned 2,006,716 shares of the company’s stock, valued at $30,100,740. This trade represents a 36.20% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, major shareholder Osage University Gp Iii, Llc bought 533,333 shares of the business’s stock in a transaction on Monday, May 11th. The shares were acquired at an average price of $15.00 per share, with a total value of $7,999,995.00. Following the transaction, the insider directly owned 2,006,716 shares of the company’s stock, valued at approximately $30,100,740. This trade represents a 36.20% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last three months, insiders have purchased 1,273,332 shares of company stock valued at $19,088,930.